Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Innoviva Inc. (INVA)

14.24   -0.13 (-0.9%) 01-24 16:00
Open: 14.37 Pre. Close: 14.37
High: 14.413 Low: 14.17
Volume: 328,568 Market Cap: 1442M
Innoviva Inc is a biopharmaceutical company that is engaged in the discovery, development and commercialization of small molecule medicines. The firm collaborates with and receives funding from GlaxoSmithKline.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 14.444 - 14.515 14.515 - 14.572
Low: 13.972 - 14.069 14.069 - 14.148
Close: 14.104 - 14.251 14.251 - 14.37

Technical analysis

as of: 2020-01-24 4:32:57 PM
Overall:       
Stoxline posted a STRONG SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 17.16     One year: 20.04
Support: Support1: 14.05    Support2: 13.66
Resistance: Resistance1: 14.69    Resistance2: 17.16
Pivot: 14.16
Moving Average: MA(5): 14.38     MA(20): 14.16
MA(100): 12.32     MA(250): 13.26
MACD: MACD(12,26): 0.23     Signal(9): 0.25
Stochastic oscillator: %K(14,3): 64.40     %D(3): 70.44
RSI: RSI(14): 57.83
52-week: High: 20.54  Low: 10.03  Change(%): -27.6
Average Vol(K): 3-Month: 63618  10-Days: 59251

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
INVA has closed below upper band by 41.8%. Bollinger Bands are 22.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

2019-10-30
Innoviva Reports Third Quarter 2019 Financial Results
BRISBANE, Calif.--(BUSINESS WIRE)--Innoviva, Inc. (NASDAQ: INVA) (the “Company”) today reported financial results for the third quarter ended September 30, 2019. Gross royalty revenues of $69.2 million from Glaxo Group Limited (“GSK”) for the third quarter of 2019 included royalties of $46.4 million from global net sales of RELVAR®/BREO® ELLIPTA®, royalties of $11.6 million from global net sales of ANORO® ELLIPTA® and $11.2 million from global net sales of TRELEGY® ELLIPTA®.[1] Total operating

2019-10-26
Is Innoviva, Inc. (INVA) Going To Burn These Hedge Funds ?
While the market driven by short-term sentiment influenced by the accomodative interest rate environment in the US, increasing oil prices and deteriorating expectations towards the resolution of the trade war with China, many smart money investors kept their cautious approach regarding the current bull

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  Nasdaq Global Select
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 101.28
Shares Float (M) 54.34
% Held by Insiders 32.51
% Held by Institutions 74.65
Shares Short (K) 11630
Shares Short P. Month (K)

Stock Financials

EPS 3.350
Book Value (p.s.) 2.640
PEG Ratio 0.44
Profit Margin 141.60
Operating Margin 93.71
Return on Assets (ttm) 32.5
Return on Equity (ttm) 458.5
Qtrly Rev. Growth 6.6
Gross Profit (p.s.) 2.577
Sales Per Share
EBITDA (p.s.) 2.452
Qtrly Earnings Growth -15.50
Operating Cash Flow (M) 252.33
Levered Free Cash Flow (M) 162.20

Stock Valuations

P/E 4.25
P/E Growth Ratio -0.01
P/BV 5.39
P/S 5.43
P/CF 5.72

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date 2015-09-29
Ex-Dividend Date 2015-09-07
Forward Dividend
Last Split Date 2014-06-02
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.